Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In
In May 2024, Shah Capital, a hedge fund in North Carolina, withdrew from its proxy fight against Novavax’s…
Browsing Tag
biopharma nl
1 post